Gillis, Jennifer L.
Grennan, Troy
Grewal, Ramandip
Ogilvie, Gina
Gaspar, Mark
Grace, Daniel
Lofters, Aisha
Raboud, Janet M.
Saarela, Olli
MacPherson, Paul
Rosenes, Ron
Salit, Irving E.
Burchell, Ann N.
,
Kroch, Abigail
Burchell, Ann
Rueda, Sergio
Arbess, Gordon
Cohen, Jeffrey
Cooper, Curtis
Lavoie, Elizabeth
Crouzat, Fred
Andany, Nisha
Walmsley, Sharon
Silverman, Michael
Sandre, Roger
Tharao, Wangari
Gauvin, Holly
Smaill, Fiona
Funding for this research was provided by:
canadian hiv trials network, canadian institutes of health research
institute of gender and health
ontario hiv treatment network
Article History
Received: 28 October 2021
Accepted: 26 October 2022
First Online: 28 December 2022
Declarations
:
: The HPV questionnaire module was approved by the HPV-SAVE Community Advisory Committee and the OCS Governance Committee. Research ethics approval for the questionnaire module and this study was received from all participating OCS sites, St. Michael’s Hospital Research Ethics Board (REB), the University Health Network REB and the University of Toronto HIV REB.
: Not applicable.
: The authors have no conflicts of interest related to this work to declare.